Experimental infection of cynomolgus monkeys with simian parvovirus

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4517-4521

  O'Sullivan, M Gerard ^a   Anderson, Deborah K ^a   Goodrich, James A ^a   Tulli, Hermina ^a   Green, Spencer W ^b   Young, Neal S ^b   Brown, Kevin E ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; MONKEY; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; RETICULOCYTE; SIMIAN VIRUS; VIREMIA; VIRUS GENE; VIRUS ISOLATION; VIRUS PATHOGENESIS; WEIGHT REDUCTION;

EID: 0030996377     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4517-4521.1997     Document Type: Article

References (33)

1. Anand, A., E. S. Gray, T. Brown, J. P. Clewley, and B. J. Cohen. 1987. Human parvovirus infection in pregnancy and hydrops fetalis. N. Engl. J. Med. 316:183-186.
2. Anderson, M. J., P. G. Higgins, L. R. Davis, J. S. Willman, S. E. Jones, I. M. Kidd, J. R. Pattison, and D. A. J. Tyrrell. 1985. Experimental parvoviral infection in humans. J. Infect. Dis. 152:257-265.
3. Anderson, M. J., S. E. Jones, S. P. Fisher-Hoch, E. Lewis, S. M. Hall, C. L. Bartlett, B. J. Cohen, P. P. Mortimer, and M. S. Pereira. 1983. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet i:1378. (Letter.)
4. Brown, K. E., S. A. Anderson, and N. S. Young. 1993. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114-117.
5. Brown, K. E., S. W. Green, J. Antunez de Mayolo, J. A. Bellanti, S. D. Smith, T. J. Smith, and N. S. Young. 1994. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 343:895-896.
6. Brown, K. E., S. W. Green, M. G. O'Sullivan, and N. S. Young. 1995. Cloning and sequencing of the simian parvovirus genome. Virology 210:314-322.
7. Brown, K. E., N. S. Young, and J. M. Liu. 1994. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit. Rev. Oncol. Hematol. 16:1-31.
8. Cossart, Y. E., A. M. Field, B. Cant, and D. Widdows. 1975. Parvovirus-like particles in human sera. Lancet i:72-73.
9. Daniel, M. D., N. W. King, and N. L. Letvin. 1984. A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. Science 223: 602-605.
10. Finkel, T. H., T. J. Török, P. J. Ferguson, E. L. Durigon, S. R. Zaki, D. Y. M. Leung, R. J. Harbeck, E. W. Gelfand, F. T. Saulsbury, J. R. Hollister, and L. J. Anderson. 1994. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343:1255-1258.
11. Frickhofen, N., J. L. Abkowitz, M. Safford, J. M. Berry, J. Antunez de Mayolo, A. Astrow, R. Cohen, I. Halperin, L. King, D. Mintzer, B. Cohen, and N. S. Young. 1990. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann. Intern. Mod. 113:926-933.
12. Hartwig, N. G., C. Vermeij-Keers, A. M. W. Van Elsacker-Niele, and G. J. Fleuren. 1989. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology 39:295-302.
13. Heberling, R. L., S. S. Kalter, and P. A. Marx. 1988. Dot immunobinding assay compared with enzyme-linked immunosorbent assay for rapid and specific detection of retrovirus antibody induced by human or simian acquired immunodeficiency syndrome. J. Clin. Microbiol. 26:765-767.
14. International Committee on Taxonomy of Viruses. 1995. Classification and nomenclature of viruses. Sixth report of the International Committee on Taxonomy of Viruses. Arch. Virol. 10(Suppl.):1-586.
15. Kajigaya, S., H. Fujii, A. Field, S. Anderson, S. Rosenfeld, L. J. Anderson, T. Simada, and N. S. Young. 1991. Self-assembled B19 parvovirus capsids. produced in a baculovirus system. Proc. Natl. Acad. Sci. USA 88:4646-4650.
16. Katz, V. L., M. C. McCoy, J. A. Kuller, and W. F. Hansen. 1996. An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am. J. Perinatol. 13:43-45.
17. Kurtzman, G., N. Frickhofen, J. Kimball, D. W. Jenkins, A. W. Nienhuis, and N. S. Young. 1989. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 321:519-523.
18. Mims, C. A. 1987. The pathogenesis of infectious disease, p. 92-253. Academic Press, Inc., New York, N.Y.
19. Morey, A. L., J. W. Keeling, H. J. Porter, and K. A. Fleming. 1992. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br. J. Obstet. Gynaecol. 99:566-574.
20. Nigro, G., M. Zerbini, A. Krzysztofiak, G. Gentilomi, M. A. Porcaro, T. Mango, and M. Musiani. 1994. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 343:1260-1261.
21. Okumura, A., and T. Ichikawa. 1993. Aseptic meningitis caused by human parvovirus B19. Arch. Dis. Child. 68:784-785.
22. O'Sullivan, M. G., D. C. Anderson, J. D. Fikes, F. T. Bain, C. S. Carlson, S. W. Green, N. S. Young, and K. E. Brown. 1994. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia: a paradigm of human B19 parvovirus infection. J. Clin. Invest. 93:1571-1576.
23. O'Sullivan, M. G., D. K. Anderson, J. E. Lund, W. P. Brown, S. W. Green, N. S. Young, and K. E. Brown. 1996. Clinical and epidemiological features of simian parvovirus infection in cynomolgus macaques with severe anemia. Lab. Anim. Sci. 46:291-297.
24. Pattison, J. R. 1994. A new parvovirus: similarities between monkeys and humans. J. Clin. Invest. 93:1354. (Editorial.)
25. Porter, H. J., A. M. Quantrill, and K. A. Fleming. 1988. B19 parvovirus infection of myocardial cells. Lancet i:535-536.
26. Potter, C. G., A. C. Potter, C. S. R. Hatton, H. M. Chapel, M. J. Anderson, J. R. Pattison, D. A. J. Tyrrell, P. G. Higgins, J. S. Wilman, H. F. Parry, and P. M. Cotes. 1987. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J. Clin. Invest. 79:1486-1492.
27. Public Health Laboratory Service Working Party on Fifth Disease. 1990. Prospective study of human parvovirus (B19) infection in pregnancy. Br. Med. J. 300:1166-1170.
28. Saint-Martin, J., J. J. Choulot, E. Bonnaud, and F. Morinet. 1990. Myocarditis caused by parvovirus. J. Pediatr. 116:1007. (Letter.)
29. Serjeant, G. R., B. E. Serjeant, P. W. Thomas, M. J. Anderson, G. Patou, and J. R. Pattison. 1993. Human parvovirus infection in homozygous sickle cell disease. Lancet 341:1237-1240.
30. Serjeant, G. R., J. M. Topley, K. Mason, B. E. Serjeant, J. R. Pattison, S. E. Jones, and R. Mohamed. 1981. Outbreak of aplastic crisis in sickle cell anaemia associated with parvovirus-like agent. Lancet ii:595-597.
31. Watanabe, T., M. Satoh, and Y. Oda. 1993. Human parvovirus encephalopathy. Arch. Dis. Child. 70:F71.
32. Weiland, H. T., C. Vermey-Keers, M. M. Salimans, G. J. Fleuren, R. A. Verwey, and M. J. Anderson. 1987. Parvovirus B19 associated with fetal abnormality. Lancet i:682-683.
33. Woolf, A. D., G. V. Campion, A. Chishick, S. Wise, B. J. Cohen, P. T. Klouda, O. Caul, and P. A. Dieppe. 1989. Clinical manifestations of human parvovirus B19 in adults. Arch. Intern. Med. 149:1153-1156.